199 related articles for article (PubMed ID: 29060933)
21. SUMO-specific protease 2 in Mdm2-mediated regulation of p53.
Jiang M; Chiu SY; Hsu W
Cell Death Differ; 2011 Jun; 18(6):1005-15. PubMed ID: 21183956
[TBL] [Abstract][Full Text] [Related]
22. Ndrg2 promoter hypermethylation triggered by helicobacter pylori infection correlates with poor patients survival in human gastric carcinoma.
Ling ZQ; Ge MH; Lu XX; Han J; Wu YC; Liu X; Zhu X; Hong LL
Oncotarget; 2015 Apr; 6(10):8210-25. PubMed ID: 25823664
[TBL] [Abstract][Full Text] [Related]
23. The protease SENP2 controls hepatic gluconeogenesis by regulating the SUMOylation of the fuel sensor AMPKα.
Dou X; Zhou WY; Ding M; Ma YJ; Yang QQ; Qian SW; Tang Y; Tang QQ; Liu Y
J Biol Chem; 2022 Feb; 298(2):101544. PubMed ID: 34971706
[TBL] [Abstract][Full Text] [Related]
24. Nucleocytoplasmic shuttling modulates activity and ubiquitination-dependent turnover of SUMO-specific protease 2.
Itahana Y; Yeh ET; Zhang Y
Mol Cell Biol; 2006 Jun; 26(12):4675-89. PubMed ID: 16738331
[TBL] [Abstract][Full Text] [Related]
25. DNA methylation of NDRG2 in gastric cancer and its clinical significance.
Chang X; Li Z; Ma J; Deng P; Zhang S; Zhi Y; Chen J; Dai D
Dig Dis Sci; 2013 Mar; 58(3):715-23. PubMed ID: 23010743
[TBL] [Abstract][Full Text] [Related]
26. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
[TBL] [Abstract][Full Text] [Related]
27. The E3 ligase UBR5 regulates gastric cancer cell growth by destabilizing the tumor suppressor GKN1.
Yang M; Jiang N; Cao QW; Ma MQ; Sun Q
Biochem Biophys Res Commun; 2016 Sep; 478(4):1624-9. PubMed ID: 27590582
[TBL] [Abstract][Full Text] [Related]
28. The SUMO-specific protease SENP2 plays an essential role in the regulation of Kv7.2 and Kv7.3 potassium channels.
Chen X; Zhang Y; Ren X; Su Q; Liu Y; Dang X; Qin Y; Yang X; Xing Z; Shen Y; Wang Y; Bai Z; Yeh ETH; Wu H; Qi Y
J Biol Chem; 2021 Oct; 297(4):101183. PubMed ID: 34509475
[TBL] [Abstract][Full Text] [Related]
29. [Expressions and significance of NDRG2 and Bcl-2 in human gastric cancer tissues].
Zhu R; Shi Y; Zhang L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Apr; 31(4):516-9. PubMed ID: 25854572
[TBL] [Abstract][Full Text] [Related]
30. SUMO-triggered ubiquitination of NR4A1 controls macrophage cell death.
Zhang L; Xie F; Zhang J; Dijke PT; Zhou F
Cell Death Differ; 2017 Sep; 24(9):1530-1539. PubMed ID: 28622293
[TBL] [Abstract][Full Text] [Related]
31. Silencing of SENP2 in Multiple Myeloma Induces Bortezomib Resistance by Activating NF-κB Through the Modulation of IκBα Sumoylation.
Xie H; Gu Y; Wang W; Wang X; Ye X; Xin C; Lu M; Reddy BA; Shu P
Sci Rep; 2020 Jan; 10(1):766. PubMed ID: 31964975
[TBL] [Abstract][Full Text] [Related]
32. SENP2 suppresses NF-κB activation and sensitizes breast cancer cells to doxorubicin.
Gao X; Wu Y; Qiao L; Feng X
Eur J Pharmacol; 2019 Jul; 854():179-186. PubMed ID: 30940449
[TBL] [Abstract][Full Text] [Related]
33. Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer.
Mirecka A; Morawiec Z; Wozniak K
Pathol Oncol Res; 2016 Oct; 22(4):817-23. PubMed ID: 27178176
[TBL] [Abstract][Full Text] [Related]
34. Senp2 regulates adipose lipid storage by de-SUMOylation of Setdb1.
Zheng Q; Cao Y; Chen Y; Wang J; Fan Q; Huang X; Wang Y; Wang T; Wang X; Ma J; Cheng J
J Mol Cell Biol; 2018 Jun; 10(3):258-266. PubMed ID: 29272473
[TBL] [Abstract][Full Text] [Related]
35. An essential role of small ubiquitin-like modifier (SUMO)-specific Protease 2 in myostatin expression and myogenesis.
Qi Y; Zuo Y; Yeh ET; Cheng J
J Biol Chem; 2014 Feb; 289(6):3288-93. PubMed ID: 24344126
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional repression of estrogen receptor α signaling by SENP2 in breast cancer cells.
Nait Achour T; Sentis S; Teyssier C; Philippat A; Lucas A; Corbo L; Cavaillès V; Jalaguier S
Mol Endocrinol; 2014 Feb; 28(2):183-96. PubMed ID: 24422630
[TBL] [Abstract][Full Text] [Related]
37. The role of sentrin-specific protease 2 substrate recognition in TGF-β-induced tumorigenesis.
Chang CC; Huang YS; Lin YM; Lin CJ; Jeng JC; Liu SM; Ho TL; Chang RT; Changou CA; Ho CC; Shih HM
Sci Rep; 2018 Jun; 8(1):9786. PubMed ID: 29955155
[TBL] [Abstract][Full Text] [Related]
38. SENP2 alleviates CCl
Bu FT; Chen Y; Yu HX; Chen X; Yang Y; Pan XY; Wang Q; Wu YT; Huang C; Meng XM; Li J
Toxicol Lett; 2018 Jun; 289():86-98. PubMed ID: 29535048
[TBL] [Abstract][Full Text] [Related]
39. SENP2 regulates MEF2A de-SUMOylation in an activity dependent manner.
Lu H; Liu B; You S; Chen L; Dongmei Q; Gu M; Lu Y; Chen Y; Zhang F; Yu B
Mol Biol Rep; 2013 Mar; 40(3):2485-90. PubMed ID: 23224591
[TBL] [Abstract][Full Text] [Related]
40. Reversible regulation of ORC2 SUMOylation by PIAS4 and SENP2.
Wang R; Liu F; Zhao Y; Wu D; Chen L; Yeh ETH; Huang C
Oncotarget; 2017 Sep; 8(41):70142-70155. PubMed ID: 29050267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
